CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2023	Jan. 31, 2022	Jan. 31, 2021
Cash flows from operating activities
Net loss	$ (274,298)	$ (290,138)	$ (83,515)
Adjustments to reconcile net loss to cash from operating activities:
Stock-based compensation expense, net of amounts capitalized	171,161	200,568	39,223
Depreciation and amortization expense	4,588	2,498	888
Non-cash operating lease cost	2,860	2,382	2,098
Other	(1)	14	57
Changes in operating assets and liabilities:
Accounts receivable	(35,556)	(33,364)	(41,407)
Deferred contract acquisition costs	(34,767)	(39,086)	(19,984)
Prepaid expenses and other assets	(61)	(13,626)	2,653
Accounts payable	(1,817)	8,464	1,093
Accrued expenses and other liabilities	2,609	(895)	3,277
Accrued compensation and benefits	1,689	32,379	7,536
Operating lease liabilities	(3,140)	(2,567)	(1,789)
Deferred revenue	78,955	75,992	46,911
Customer deposits	3,316	1,164	3,336
Net cash used in operating activities	(84,462)	(56,215)	(39,623)
Cash flows from investing activities
Purchases of property and equipment	(252)	(214)	(4,304)
Capitalized internal-use software	(8,746)	(6,382)	(2,920)
Purchase of short-term investments	0	0	(50,000)
Proceeds from maturities of short-term investments	0	0	80,000
Net cash (used in) provided by investing activities	(8,998)	(6,596)	22,776
Cash flows from financing activities
Proceeds from initial public offering, net of underwriting discounts and commissions	0	1,252,974	0
Taxes paid related to net share settlement of equity awards	(248)	(105,642)	0
Payments of loan issuance costs	0	0	(229)
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs	0	0	174,724
Proceeds from issuance of common stock upon exercise of stock options	5,034	5,036	2,629
Proceeds from issuance of common stock under employee stock purchase plan	17,197	0	0
Payments of deferred offering costs	0	(4,522)	0
Net cash provided by financing activities	21,983	1,147,846	177,124
Net (decrease) increase in cash, cash equivalents, and restricted cash	(71,477)	1,085,035	160,277
Cash, cash equivalents, and restricted cash beginning of period	1,357,611	272,576	112,299
Cash, cash equivalents, and restricted cash end of period	1,286,134	1,357,611	272,576
Supplemental disclosure of cash flow information
Cash paid for income taxes, net of refund received	999	739	452
Cash paid for operating lease liabilities	3,781	3,291	2,479
Supplemental disclosure of noncash investing and financing activities
Operating lease right-of-use assets obtained in exchange for new lease obligations	0	2,036	0
Unpaid deferred offering costs	0	1,527	0
Unpaid taxes related to net share settlement of equity awards	0	5,347	0
Conversion of convertible preferred stock to common stock upon initial public offering	0	349,113	0
Capitalized stock-based compensation expense	$ 4,207	$ 3,562	$ 0